Stay updated on Upadacitinib Study in RA Patients: China & Global Countries Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib Study in RA Patients: China & Global Countries Clinical Trial page.

Latest updates to the Upadacitinib Study in RA Patients: China & Global Countries Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page footer now shows Revision: v3.6.3, replacing the previous v3.6.2. This reflects a small backend or UI update that does not modify the study details.SummaryDifference0.0%

- Check26 days agoChange DetectedThe page now shows Revision: v3.6.2 in place of Revision: v3.6.0, indicating an updated documentation or UI version reference.SummaryDifference0.0%

- Check40 days agoChange DetectedThe Study Details navigation headers were updated to standardize the Intervention/Treatment label and to add new help sections including 'How to Read a Study Record,' 'Common Questions,' and 'How to Join a Study,' while removing the old 'Intervention / Treatment' header. A recruitment status indicator 'No longer looking for participants' was added, and the site revision label was updated from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check47 days agoChange DetectedThe page’s revision tag changed from v3.5.4 to v3.5.5, indicating a new release of the page or its underlying components.SummaryDifference0.0%

- Check68 days agoChange DetectedRevision label v3.5.4 was added and the previous label v3.5.3 was removed, reflecting an update to the page's version metadata. This change does not alter the substantive content or functionality of the page.SummaryDifference0.0%

- Check90 days agoChange DetectedThe page now shows an updated ClinicalTrials.gov site revision/version number (v3.5.3 rather than v3.5.2).SummaryDifference0.0%

Stay in the know with updates to Upadacitinib Study in RA Patients: China & Global Countries Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib Study in RA Patients: China & Global Countries Clinical Trial page.